
Patrick M. Fernandes
Examiner (ID: 8787, Phone: (571)272-7706 , Office: P/3736 )
| Most Active Art Unit | 3791 |
| Art Unit(s) | 3736, 3791 |
| Total Applications | 613 |
| Issued Applications | 344 |
| Pending Applications | 74 |
| Abandoned Applications | 222 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12983395
[patent_doc_number] => 20170343455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => Methods Of Reducing Viscosity Of Biological Samples
[patent_app_type] => utility
[patent_app_number] => 15/604809
[patent_app_country] => US
[patent_app_date] => 2017-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10681
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15604809
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/604809 | Methods of reducing viscosity of biological samples | May 24, 2017 | Issued |
Array
(
[id] => 11957367
[patent_doc_number] => 20170261520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'Markers Associated With Arteriovascular Events And Methods Of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 15/602502
[patent_app_country] => US
[patent_app_date] => 2017-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 253
[patent_figures_cnt] => 253
[patent_no_of_words] => 66925
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15602502
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/602502 | Markers Associated With Arteriovascular Events And Methods Of Use Thereof | May 22, 2017 | Abandoned |
Array
(
[id] => 17621170
[patent_doc_number] => 11340218
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-24
[patent_title] => Method for preparing a biological sample for use in an immunolabeling process
[patent_app_type] => utility
[patent_app_number] => 16/303360
[patent_app_country] => US
[patent_app_date] => 2017-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4825
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16303360
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/303360 | Method for preparing a biological sample for use in an immunolabeling process | May 21, 2017 | Issued |
Array
(
[id] => 12032104
[patent_doc_number] => 20170322203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'POINT OF CARE IMMUNIZATION TESTING SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 15/599775
[patent_app_country] => US
[patent_app_date] => 2017-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11223
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15599775
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/599775 | Immunization testing system | May 18, 2017 | Issued |
Array
(
[id] => 12060083
[patent_doc_number] => 20170336428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'RFID Tracking Systems And Methods'
[patent_app_type] => utility
[patent_app_number] => 15/598449
[patent_app_country] => US
[patent_app_date] => 2017-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12526
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15598449
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/598449 | RFID Tracking Systems And Methods | May 17, 2017 | Abandoned |
Array
(
[id] => 16514203
[patent_doc_number] => 20200393461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => USE OF ANTI-CD26 ANTIBODY LEVELS AS AUTOIMMUNE AND/OR INFLAMMATORY DISEASE BIOMARKERS
[patent_app_type] => utility
[patent_app_number] => 16/300494
[patent_app_country] => US
[patent_app_date] => 2017-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22578
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16300494
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/300494 | USE OF ANTI-CD26 ANTIBODY LEVELS AS AUTOIMMUNE AND/OR INFLAMMATORY DISEASE BIOMARKERS | May 11, 2017 | Abandoned |
Array
(
[id] => 13198227
[patent_doc_number] => 10114029
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-30
[patent_title] => Method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction
[patent_app_type] => utility
[patent_app_number] => 15/590571
[patent_app_country] => US
[patent_app_date] => 2017-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 22
[patent_no_of_words] => 10892
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15590571
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/590571 | Method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction | May 8, 2017 | Issued |
Array
(
[id] => 17923922
[patent_doc_number] => 11467162
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-11
[patent_title] => Diagnostic test for hepatocellular carcinoma
[patent_app_type] => utility
[patent_app_number] => 16/099240
[patent_app_country] => US
[patent_app_date] => 2017-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8482
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16099240
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/099240 | Diagnostic test for hepatocellular carcinoma | May 7, 2017 | Issued |
Array
(
[id] => 14375217
[patent_doc_number] => 20190161521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-30
[patent_title] => ANTIBODY BINDING NANOFIBRILS
[patent_app_type] => utility
[patent_app_number] => 16/301075
[patent_app_country] => US
[patent_app_date] => 2017-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11311
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16301075
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/301075 | Antibody binding nanofibrils | May 7, 2017 | Issued |
Array
(
[id] => 12173086
[patent_doc_number] => 09891222
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-13
[patent_title] => 'Methods and compositions for identification and quantification of ENOX2 transcript variants as indications of cancer presence in blood serum and other body fluids based on gold or silver nanoparticle formation'
[patent_app_type] => utility
[patent_app_number] => 15/587072
[patent_app_country] => US
[patent_app_date] => 2017-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 6400
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15587072
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/587072 | Methods and compositions for identification and quantification of ENOX2 transcript variants as indications of cancer presence in blood serum and other body fluids based on gold or silver nanoparticle formation | May 3, 2017 | Issued |
Array
(
[id] => 12842557
[patent_doc_number] => 20180172692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => TARGET-BINDING ACTIVATED SPLIT REPORTER SYSTEMS FOR ANALYTE DETECTION AND RELATED COMPONENTS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 15/498291
[patent_app_country] => US
[patent_app_date] => 2017-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15227
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -78
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15498291
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/498291 | Target-binding activated split reporter systems for analyte detection and related components and methods | Apr 25, 2017 | Issued |
Array
(
[id] => 17000584
[patent_doc_number] => 11079388
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-03
[patent_title] => Super-resolution immunofluorescence with diffraction-limited preview
[patent_app_type] => utility
[patent_app_number] => 16/094954
[patent_app_country] => US
[patent_app_date] => 2017-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 8109
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16094954
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/094954 | Super-resolution immunofluorescence with diffraction-limited preview | Apr 24, 2017 | Issued |
Array
(
[id] => 15529515
[patent_doc_number] => 20200057063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => METHOD FOR DETECTING PRESENCE OF A THIOETHER AND KIT FOR DETECTING SAME
[patent_app_type] => utility
[patent_app_number] => 16/608153
[patent_app_country] => US
[patent_app_date] => 2017-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5193
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16608153
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/608153 | METHOD FOR DETECTING PRESENCE OF A THIOETHER AND KIT FOR DETECTING SAME | Apr 23, 2017 | Abandoned |
Array
(
[id] => 14187637
[patent_doc_number] => 20190113523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => HUMORAL IMMUNITY SIGNATURES FOR ANTIBODY-MEDIATED IMMUNE RESPONSES AND TREATMENTS
[patent_app_type] => utility
[patent_app_number] => 16/093839
[patent_app_country] => US
[patent_app_date] => 2017-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23336
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16093839
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/093839 | HUMORAL IMMUNITY SIGNATURES FOR ANTIBODY-MEDIATED IMMUNE RESPONSES AND TREATMENTS | Apr 18, 2017 | Abandoned |
Array
(
[id] => 15543391
[patent_doc_number] => 10571467
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-25
[patent_title] => Methods for prediction of anti-TNFa drug levels and autoantibody formation
[patent_app_type] => utility
[patent_app_number] => 15/486072
[patent_app_country] => US
[patent_app_date] => 2017-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 42
[patent_no_of_words] => 17600
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15486072
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/486072 | Methods for prediction of anti-TNFa drug levels and autoantibody formation | Apr 11, 2017 | Issued |
Array
(
[id] => 14105095
[patent_doc_number] => 20190094223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => INFILTRATING IMMUNE CELL PROPORTIONS PREDICT ANTI-TNF RESPONSE IN COLON BIOPSIES
[patent_app_type] => utility
[patent_app_number] => 16/091988
[patent_app_country] => US
[patent_app_date] => 2017-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31540
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091988
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/091988 | Infiltrating immune cell proportions predict anti-TNF response in colon biopsies | Apr 5, 2017 | Issued |
Array
(
[id] => 14187639
[patent_doc_number] => 20190113524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => METHOD FOR DETERMINING MORBIDITY TO DIABETES
[patent_app_type] => utility
[patent_app_number] => 16/088699
[patent_app_country] => US
[patent_app_date] => 2017-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13198
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16088699
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/088699 | METHOD FOR DETERMINING MORBIDITY TO DIABETES | Mar 29, 2017 | Abandoned |
Array
(
[id] => 16400156
[patent_doc_number] => 20200341014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => PD Marker of Hepatocyte Growth Factor (HGF)
[patent_app_type] => utility
[patent_app_number] => 16/078557
[patent_app_country] => US
[patent_app_date] => 2017-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8164
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16078557
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/078557 | PD Marker of Hepatocyte Growth Factor (HGF) | Mar 15, 2017 | Abandoned |
Array
(
[id] => 13182147
[patent_doc_number] => 10106575
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-23
[patent_title] => Biomarkers
[patent_app_type] => utility
[patent_app_number] => 15/461326
[patent_app_country] => US
[patent_app_date] => 2017-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 24860
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15461326
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/461326 | Biomarkers | Mar 15, 2017 | Issued |
Array
(
[id] => 14216949
[patent_doc_number] => 20190120859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => METHOD FOR DETECTING AGGREGATE OF AGGREGATE-FORMING POLYPEPTIDE
[patent_app_type] => utility
[patent_app_number] => 16/085070
[patent_app_country] => US
[patent_app_date] => 2017-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6014
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085070
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/085070 | Method for detecting aggregate of aggregate-forming polypeptide | Mar 15, 2017 | Issued |